EX-FILING FEES 4 ea178928ex-fee_altamirathe.htm FILING FEE TABLE

Exhibit 107

 

Calculation of Filing Fee Tables

 

Form F-1

(Form Type)

 

Altamira Therapeutics Ltd.

(Exact Name of Registrant as Specified in its Charter)

 

Not Applicable

(Translation of Registrant’s Name into English)

 

   Security
Type		  Security Class
Title		  Fee
Calculation
or Carry
Forward
Rule		  Amount Registered (1)   Proposed
Maximum Offering
Price Per
Unit (2)		   Maximum
Aggregate
Offering
Price		   Fee Rate   Amount of
Registration
Fee		 
Fees to Be
Paid		  Equity  Common shares, par value CHF 0.20 per share  Other   2,500,000   $0.7849   $1,962,250    0.0001102   $216.24 
   Total Offering Amounts        $1,962,250        $

216.24

 
   Total Fees Previously Paid                  $0 
   Total Fee Offsets                  $

216.24

 
   Net Fee Due                  $0 

 

 Table 2: Fee Offset Claims and Sources

 

   Registrant
or Filer
Name		  Form
or
Filing
Type		   File
Number		   Initial
Filing
Date		   Filing
Date		   Fee
Offset
Claimed		   Security
Type
Associated
with Fee
Offset
Claimed		   Security
Title
Associated
with Fee
Offset
Claimed		   Unsold
Securities
Associated
with Fee
Offset
Claimed		   Aggregate
Offering
Amount
Associated
with Fee
Offset
Claimed		   Fee Paid
with Fee
Offset Source		 
Rules 457(b) and 0-11(a)(2)
Fee Offset
Claims		                                        
Fee Offset
Sources		                                                     
Rule 457(p)
Fee Offset
Claims		  Altamira Therapeutics Ltd.    F-1     333-269823    02/16/2023        $216.24    Equity    (3)   (3)   (3)     
Fee Offset
Sources		   Altamira Therapeutics Ltd.   F-1    333-269823         03/27/2023                            $2,230.45 

 

(1)Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall also cover any additional common shares that become issuable pursuant to that certain purchase agreement by and between Altamira Therapeutics Ltd. (the “Registrant”) and Lincoln Park Capital Fund, LLC (“LPC) dated as of December 5, 2022, relating to the issuance of up to $10,000,000 of common shares of the Registrant (the “Purchase Agreement”) by reason of any non-cash dividend, share split, reverse share split, recapitalization, or other similar transaction effected that results in an increase to the number of outstanding common shares, as applicable. Includes up to 2,500,000 common shares of the Registrant that are available to be issued and sold by the Registrant to LPC from time to time at the Registrant’s election pursuant to the Purchase Agreement, subject to satisfaction of the conditions set forth therein.

 

  (2)

Estimated pursuant to Rules 457(c) under the Securities Act, solely for the purposes of calculating the registration fee and based on the average of the high and low prices of the Registrant’s common shares as reported on The Nasdaq Capital Market on May 31, 2023, which date is within five business days prior to the filing of this registration statement. 

 

(3)The registrant previously paid a filing fee of $2,230.45 in connection with the registration of up to an aggregate of $20,240,000 of common shares, par value CHF 0.20 per share (the “Common Shares”), Common Shares underlying pre-funded warrants and Common Shares underlying common warrants under the registrant’s registration statement on Form F-1 (File No. 333-269823) (the “Prior Registration Statement”). The registration fee shown on the table above is offset by $216.24 in fees that the registrant is entitled to offset under Rule 457(p) of the Securities Act, which the registrant previously paid with respect to unsold shares under the Prior Registration Statement. The registrant has withdrawn the Prior Registration Statement.